Our story
From medical nutrition to everyday recovery
The science behind Amizate began in university laboratories, with research into medical nutrition and how amino acids and peptides could be naturally extracted from fish protein and made readily available to the body.
Over time, this research developed into a unique natural enzymatic process that we now produce at industrial scale.
What started as medical nutrition research has evolved into nutrition for everyday life, supporting medical nutrition, sports & endurance, healthy ageing and wellness.
The history
Zymtech Production AS was established in 1997 with the goal of developing an industrial process to extract amino acids, short peptides and micronutrients from salmon protein. Building on earlier scientific research and university laboratory trials, the company successfully scaled the technology and developed the unique natural enzymatic process used to produce the protein hydrolysate later named AMIZATE®.
In 2000, a food processing plant was acquired and, over the following years, converted into a dedicated biotech production facility. Extensive process development, testing and facility upgrades followed as the technology moved from laboratory research to industrial-scale production.
During this period, three process patent applications were filed and significant investment was made in further developing the technology and its potential applications.
In 2007, product patent applications were filed for the “Amino Acid and Peptide Product.” In the years that followed, extensive product development and clinical research continued.
In 2018, Zymtech Production AS was acquired by Icelandic investors and the business continued under Zymtech Life Science AS, marking a new chapter in the development and commercialization of AMIZATE®.
Today, we produce AMIZATE® at industrial scale using our unique natural enzymatic process, bringing decades of research and development into applications across medical nutrition, healthy ageing, active lifestyles and performance.
From 2010 the plant started to regularly produce high quality product. A new quality and laboratory manager for the factory renewed the food approval status of the plant with the Norwegian Food Safety Authority. Implementation of extensive quality upgrades including HAACP quality standards in the production took place.
From 2011 – 2012 the company progressed on the product and market development side with new formulations for the sport nutrition segment, and products for health and general wellbeing.
In 2013, a further capital injection took place to strengthen the company. Key focus was on regulatory approval processes for key markets.
In 2014 regulatory approvals were obtained in United States (GRAS), EU and selected markets in Asia. Further successful clinical studies were conducted and strategic alliances established.
In 2018 the processing plant ownership changed to Zymtech Life Science A/S.
In 2019 a new branded product called Unbroken® was launched by Unbroken ehf, a sister company of Zymtech Life Science A/S. The key active product ingredient is AMIZATE®. For more information, visit www.unbrokenrtr.com.
